Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin W Besser

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Hemoglobin|October 18, 2018
Hb Penang [β78(EF2)Leu→Pro, HBB: c.236T>C]: a Novel β-Globin VariantCatherine H-W Hsu, Jonathan Langdown, Roderick Lynn, et al.
Journal of Clinical Pathology|July 3, 2015
Clinical use of low haemoglobin density, transferrin saturation, bone marrow morphology, Perl's stain and other plasma markers in the identification of treatable anaemia presenting for cardiac surgery in a prospective cohort studyPedro Martin-Cabrera, Matthew Hung, Erik Ortmann, et al.
Blood|May 9, 2019
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disordersKate Downes, Karyn Megy, Daniel Duarte, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Hemoglobin|October 18, 2018
Hb Penang [β78(EF2)Leu→Pro, HBB: c.236T>C]: a Novel β-Globin VariantCatherine H-W Hsu, Jonathan Langdown, Roderick Lynn, et al.
Journal of Clinical Pathology|July 3, 2015
Clinical use of low haemoglobin density, transferrin saturation, bone marrow morphology, Perl's stain and other plasma markers in the identification of treatable anaemia presenting for cardiac surgery in a prospective cohort studyPedro Martin-Cabrera, Matthew Hung, Erik Ortmann, et al.
Blood|May 9, 2019
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disordersKate Downes, Karyn Megy, Daniel Duarte, et al.
Pageof 2